Log in to save to my catalogue

Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomise...

Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomise...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2239146956

Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study

About this item

Full title

Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study

Publisher

England: Elsevier Ltd

Journal title

Lancet neurology, 2019-07, Vol.18 (7), p.631-642

Language

English

Formats

Publication information

Publisher

England: Elsevier Ltd

More information

Scope and Contents

Contents

Pantothenate kinase-associated neurodegeneration (PKAN) is a rare genetic disorder characterised by progressive generalised dystonia and brain iron accumulation. We assessed whether the iron chelator deferiprone can reduce brain iron and slow disease progression.
We did an 18-month, randomised, double-blind, placebo-controlled trial (TIRCON2012V...

Alternative Titles

Full title

Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2239146956

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2239146956

Other Identifiers

ISSN

1474-4422

E-ISSN

1474-4465

DOI

10.1016/S1474-4422(19)30142-5

How to access this item